Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Asma S Algahmdi"'
Autor:
Silvana Debernardi, Harrison O'Brien, Asma S Algahmdi, Nuria Malats, Grant D Stewart, Marija Plješa-Ercegovac, Eithne Costello, William Greenhalf, Amina Saad, Rhiannon Roberts, Alexander Ney, Stephen P Pereira, Hemant M Kocher, Stephen Duffy, Oleg Blyuss, Tatjana Crnogorac-Jurcevic
Publikováno v:
PLoS Medicine, Vol 17, Iss 12, p e1003489 (2020)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with around 9% of patients surviving >5 years. Asymptomatic in its initial stages, PDAC is mostly diagnosed late, when already a locally advanced or metastatic disease
Externí odkaz:
https://doaj.org/article/758ce4bbd92c47ee997f083080f5b0de
Autor:
Marija Pljesa-Ercegovac, Eithne Costello, Stephen W. Duffy, Hemant M. Kocher, William Greenhalf, Rhiannon Roberts, Asma S. Algahmdi, Oleg Blyuss, Núria Malats, Amina Saad, Alexander Ney, Harrison O’Brien, Grant D. Stewart, Silvana Debernardi, Stephen P. Pereira, Tatjana Crnogorac-Jurcevic
Publikováno v:
PLoS Medicine, Vol 17, Iss 12, p e1003489 (2020)
PLOS MEDICINE
PLoS Medicine
PLOS MEDICINE
PLoS Medicine
Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with around 9% of patients surviving >5 years. Asymptomatic in its initial stages, PDAC is mostly diagnosed late, when already a locally advanced or metastatic diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::619d4f848c756a47866c44cafd842b82
https://doi.org/10.1371/journal.pmed.1003489
https://doi.org/10.1371/journal.pmed.1003489